关注
Roman M. Shapiro
Roman M. Shapiro
Instructor
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
RM Shapiro, GC Birch, G Hu, JV Cadavid, S Nikiforow, J Baginska, AK Ali, ...
The Journal of clinical investigation 132 (11), 2022
642022
Key aspects of the immunobiology of haploidentical hematopoietic cell transplantation
SHC Baumeister, B Rambaldi, RM Shapiro, R Romee
Frontiers in Immunology 11, 504873, 2020
482020
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
JS Garcia, HT Kim, HM Murdock, CS Cutler, J Brock, M Gooptu, VT Ho, ...
Blood Advances 5 (24), 5536-5545, 2021
292021
Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape
RM Shapiro, JH Antin
Expert Review of Hematology 13 (5), 519-532, 2020
292020
Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia
RM Shapiro, A Lazo-Langner
BMC hematology 18, 1-9, 2018
292018
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
K Maurer, HT Kim, TM Kuczmarski, HM Garrity, A Weber, CG Reynolds, ...
Blood Advances 5 (23), 5140-5149, 2021
282021
Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or …
RM Shapiro, DDH Kim
Current Opinion in Hematology 25 (6), 425-432, 2018
272018
Innovative strategies to improve the clinical application of NK cell-based immunotherapy
M Tarannum, R Romee, RM Shapiro
Frontiers in Immunology 13, 859177, 2022
242022
Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti-Pr specificity
R Shapiro, I Chin-Yee, S Lam
Clinical Case Reports 3 (11), 942, 2015
242015
Ibrutinib in steroid-refractory chronic graft-versus-host disease, a single-center experience
KK Chin, HT Kim, EA Inyang, V Ho, J Koreth, R Romee, M Gooptu, ...
Transplantation and Cellular Therapy 27 (12), 990. e1-990. e7, 2021
222021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
VT Ho, HT Kim, J Brock, I Galinsky, H Daley, C Reynolds, A Weber, ...
Blood Advances 6 (7), 2183-2194, 2022
152022
Extensive bone marrow necrosis in a case of acute myeloid leukemia transformed from a myeloproliferative neoplasm
R Shapiro, K Rizkalla, S Lam
Case Reports in Oncology 8 (2), 345-348, 2015
122015
Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
K Maurer, VT Ho, E Inyang, C Cutler, J Koreth, RM Shapiro, M Gooptu, ...
Blood Advances 7 (15), 3903-3915, 2023
102023
Cytokine-induced memory-like NK cells exhibit massive expansion and long-term persistence after infusion post-haploidentical stem cell transplantation: a report of the first …
RM Shapiro, S Nikiforow, B Rambaldi, J Vergara, H Daley, HT Kim, ...
Blood 136, 8-9, 2020
82020
Invasive yeast infection after haploidentical donor hematopoietic cell transplantation associated with cytokine release syndrome
JS Little, RM Shapiro, MM Aleissa, A Kim, JBP Chang, DW Kubiak, ...
Transplantation and cellular therapy 28 (8), 508. e1-508. e8, 2022
72022
Initial transfusion intensity predicts survival in myelodysplastic syndrome
LSA Chan, R Shapiro, R Buckstein, Y Lin, J Callum, L Chodirker, CD Lee, ...
Leukemia & Lymphoma 55 (10), 2296-2300, 2014
72014
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
K Maurer, HT Kim, HM Garrity, D Liney, C Cutler, JH Antin, J Koreth, J Ritz, ...
Blood Advances 7 (11), 2431, 2023
62023
The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors
S Piccinelli, R Romee, RM Shapiro
Seminars in Hematology 60 (1), 42-51, 2023
62023
Blastic plasmacytoid dendritic cell neoplasm: a review of diagnosis, pathology, and therapy
R Shapiro, N Sangle, M Keeney, IH Chin-Yee, CC Hsia, S Lam
J Cell Sci Ther 8, 008, 2015
42015
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft
JS Little, R Duléry, RM Shapiro, MM Aleissa, SE Prockop, J Koreth, J Ritz, ...
Transplantation and Cellular Therapy 30 (2), 233. e1-233. e14, 2024
32024
系统目前无法执行此操作,请稍后再试。
文章 1–20